<code id='8EE1B9176A'></code><style id='8EE1B9176A'></style>
    • <acronym id='8EE1B9176A'></acronym>
      <center id='8EE1B9176A'><center id='8EE1B9176A'><tfoot id='8EE1B9176A'></tfoot></center><abbr id='8EE1B9176A'><dir id='8EE1B9176A'><tfoot id='8EE1B9176A'></tfoot><noframes id='8EE1B9176A'>

    • <optgroup id='8EE1B9176A'><strike id='8EE1B9176A'><sup id='8EE1B9176A'></sup></strike><code id='8EE1B9176A'></code></optgroup>
        1. <b id='8EE1B9176A'><label id='8EE1B9176A'><select id='8EE1B9176A'><dt id='8EE1B9176A'><span id='8EE1B9176A'></span></dt></select></label></b><u id='8EE1B9176A'></u>
          <i id='8EE1B9176A'><strike id='8EE1B9176A'><tt id='8EE1B9176A'><pre id='8EE1B9176A'></pre></tt></strike></i>

          leisure time

          leisure time

          author:knowledge    Page View:483
          Beth Israel Deaconess Medical Center in Boston
          David L. Ryan/The Boston Globe

          Steward Health Care’s Massachusetts hospitals are on the brink of financial disaster. But in many important ways, Steward’s troubles are just a symptom of a larger crisis engulfing the entire industry.

          While Steward’s for-profit ownership structure put its hospitals at a disadvantage, many health care executives say the state’s entire network of hospitals is approaching a capacity shortage not seen since the early days of the Covid-19 pandemic.

          advertisement

          Industry leaders are calling for urgent action from the Healey administration and the Legislature to help stem the crisis. Even just simplifying the state regulatory bureaucracy and approvals for bringing uninsured patients into the MassHealth system would help, executives say.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more
          Acelyrin, a rare IPO success, stumbles in its first big test
          Acelyrin, a rare IPO success, stumbles in its first big test

          MarkLennihan/APThebiotechcompanyAcelyrin,whichraisedmorethan$500millioninanIPOthisyear,ranintoitsfir

          read more
          Guidelines to prevent youth baseball injuries need more muscle
          Guidelines to prevent youth baseball injuries need more muscle

          Apitcheratthe2018LittleLeagueWorldSeries.RobCarr/GettyImages“Weallknowthatweareinthemiddleofanepidem

          read more

          Why the world’s most expensive drug might be worth the price

          AdobeThestaffoftheInstituteforClinicalandEconomicReview,orICER,areknownasthenerdsofthedrugindustry:b